About this course

  • Released: 03/18/2013
  • Expires: 03/19/2015

Learning Objectives:

Upon completion of the article by Squitieri et al, the participant should be able to:
• State the proposed mechanism of action of pridopidine
• Discuss common adverse events associated with use of pridopidine
• State serious or life-threatening adverse events associated with use of pridopidine

Core Competencies:

The article by Squitieri et al covers the following core competency:
• Medical Knowledge


Learning Objectives:

Upon completion of the article by O'Toole et al, the participant should be able to:
• Describe clinical characteristics of patients with paraneoplastic autoimmune chorea
• Describe clinical characteristics of patients with idiopathic autoimmune chorea
• Compare the clinical features of patients with paraneoplastic autoimmune chorea with those with idiopathic autoimmune chorea

Core Competencies:

The article by O'Toole et al covers the following core competency:
• Medical Knowledge


Author Disclosures
Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

ACCME